Nancy R. Cook

Cardiology and Cardiovascular Medicine · 2001–2021

A researcher in the Science corpus: 16 papers; trusts 7 researchers and is trusted by 57 researchers here, as inferred from the citation graph.

Subfields

Whom Nancy R. Cook trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Peihua Qiu
  2. James A. Hanley
  3. Jr. Frank E. Harrell
  4. Alejandro Rabinstein
  5. Esteban Walker
  6. M. Pepe
  7. Nancy A. Obuchowski
  8. Michael J. Pencina
  9. P. Ridker
  10. Peter W. F. Wilson

Who trusts Nancy R. Cook overall

  1. Jay P. Singh
  2. Ewout W. Steyerberg
  3. Chava L. Ramspek
  4. Davide Chicco
  5. P. Ridker
  6. Karel G. M. Moons
  7. M. Pepe
  8. Alvin Rajkomar
  9. Benjamin Alan Goldstein
  10. D. Hans

Papers from Nancy R. Cook's perspective

Ordered by how strongly the researchers Nancy R. Cook trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The Statistical Evaluation of Medical Tests for Classification and Prediction
  2. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction (Circulation)
  3. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. (American Journal of Epidemiology)
  4. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond (Statistics in Medicine)
  5. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. (The Lancet)
  6. Estimation of time‐dependent area under the ROC curve for long‐term risk prediction (Statistics in Medicine)
  7. What do we mean by validating a prognostic model? (Statistics in Medicine)
  8. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis
  9. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. (Clinical Chemistry)
  10. Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). (Circulation)

Their papers